Codexis Inc (CDXS)
3.53
-0.03
(-0.84%)
USD |
NASDAQ |
May 07, 16:00
3.53
0.00 (0.00%)
After-Hours: 20:00
Codexis Cash from Financing (TTM): 36.10M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 36.10M |
December 31, 2023 | 8.167M |
September 30, 2023 | 8.506M |
June 30, 2023 | 8.747M |
March 31, 2023 | 2.057M |
December 31, 2022 | -0.575M |
September 30, 2022 | 1.512M |
June 30, 2022 | 2.247M |
March 31, 2022 | 2.47M |
December 31, 2021 | 3.767M |
September 30, 2021 | 82.93M |
June 30, 2021 | 82.18M |
March 31, 2021 | 81.84M |
December 31, 2020 | 80.81M |
September 30, 2020 | 1.644M |
June 30, 2020 | 3.207M |
March 31, 2020 | 55.02M |
December 31, 2019 | 53.96M |
September 30, 2019 | 51.79M |
June 30, 2019 | 52.50M |
March 31, 2019 | 39.25M |
December 31, 2018 | 38.57M |
September 30, 2018 | 38.35M |
June 30, 2018 | 35.83M |
March 31, 2018 | 20.43M |
Date | Value |
---|---|
December 31, 2017 | 21.65M |
September 30, 2017 | 21.71M |
June 30, 2017 | 21.91M |
March 31, 2017 | -0.946M |
December 31, 2016 | -0.49M |
September 30, 2016 | -0.531M |
June 30, 2016 | -0.569M |
March 31, 2016 | -2.182M |
December 31, 2015 | -1.524M |
September 30, 2015 | -1.553M |
June 30, 2015 | -1.946M |
March 31, 2015 | -0.876M |
December 31, 2014 | -0.611M |
September 30, 2014 | -1.07M |
June 30, 2014 | -0.709M |
March 31, 2014 | -0.578M |
December 31, 2013 | -0.147M |
September 30, 2013 | 0.651M |
June 30, 2013 | 1.251M |
March 31, 2013 | 1.426M |
December 31, 2012 | 1.257M |
September 30, 2012 | 0.997M |
June 30, 2012 | 0.476M |
March 31, 2012 | 1.188M |
December 31, 2011 | 2.579M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.575M
Minimum
Dec 2022
82.93M
Maximum
Sep 2021
30.94M
Average
8.626M
Median
Cash from Financing (TTM) Benchmarks
Avidity Biosciences Inc | 93.86M |
Taysha Gene Therapies Inc | 136.39M |
Janux Therapeutics Inc | 59.55M |
Tango Therapeutics Inc | 82.41M |
2seventy bio Inc | 127.39M |